Skip to main content
Premium Trial:

Request an Annual Quote

Oh, the Pressure

Pressure to publish scientific papers has led to the ability to publish just about anything, whether the paper merits publication or not, writes University College London's David Colquhoun in the Guardian. Colquhoun notes that a department at his institution had "productivity" targets, namely that researchers should publish three papers a year, one of which should be in a high-impact-factor journal. "The effect of instructions like that is to reduce the quality of science and to demoralise the victims of this sort of mismanagement," he says. Colquhoun adds that the only beneficiaries of the pressure to publish are publishers.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.